INS and metabolic disease: Future studies are warranted to further elucidate the function of insulin signaling and estrogen signaling, especially their cross-talk in specific tissues and at global level, for the purpose of preventing dysfunctional hormone-related metabolic diseases and designing new therapeutic strategies.